Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation.
Bioorg Med Chem Lett
; 30(13): 127197, 2020 07 01.
Article
en En
| MEDLINE
| ID: mdl-32331932
ABSTRACT
A novel series of ethyl ketone based HDACs 1, 2, and 3 selective inhibitors have been identified with good enzymatic and cellular activity and high selectivity over HDACs 6 and 8. These inhibitors contain a spirobicyclic group in the amide region. Compound 13 stands out as a lead due to its good potency, high selectivity, and reasonable rat and dog PK. Compounds 33 and 34 show good potency and rat PK profiles as well.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Activación Viral
/
VIH-1
/
Latencia del Virus
/
Fármacos Anti-VIH
/
Inhibidores de Histona Desacetilasas
/
Cetonas
Límite:
Animals
/
Humans
Idioma:
En
Año:
2020
Tipo del documento:
Article